Onconova Therapeutics Analyst Ratings
Onconova Therapeutics Analyst Ratings
While ratings are subjective and will change, the latest Onconova Therapeutics (ONTX) rating was a reiterated with a price target of $11.00 to $11.00. The current price Onconova Therapeutics (ONTX) is trading at is $0.78, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/12/2023 | 1310.26% | HC Wainwright & Co. | $11 → $11 | Reiterates | Buy → Buy |
| 08/11/2023 | 1310.26% | HC Wainwright & Co. | → $11 | Reiterates | Buy → Buy |
| 06/14/2023 | 1310.26% | HC Wainwright & Co. | → $11 | Reiterates | → Buy |
| 06/06/2023 | 1310.26% | HC Wainwright & Co. | → $11 | Reiterates | Buy → Buy |
| 05/25/2023 | 1310.26% | HC Wainwright & Co. | → $11 | Reiterates | → Buy |
| 05/16/2023 | 1310.26% | HC Wainwright & Co. | → $11 | Reiterates | Buy → Buy |
| 04/21/2023 | 1310.26% | HC Wainwright & Co. | → $11 | Upgrades | Neutral → Buy |
| 03/01/2022 | 797.44% | Ladenburg Thalmann | → $7 | Initiates Coverage On | → Buy |
| 05/18/2021 | 412.82% | Guggenheim | → $4 | Initiates Coverage On | → Buy |
| 12/22/2020 | — | Noble Capital Markets | Upgrades | Market Perform → Outperform | |
| 08/24/2020 | — | HC Wainwright & Co. | Downgrades | Buy → Neutral | |
| 07/25/2019 | 1438.46% | Noble Capital Markets | → $12 | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 2023 年 12 月 10 日 | 1310.26% | HC Wainwright & Co. | 11 美元 → 11 美元 | 重申 | 購買 → 購買 |
| 08/11/2023 | 1310.26% | HC Wainwright & Co. | → 11 美元 | 重申 | 購買 → 購買 |
| 06/14/2023 | 1310.26% | HC Wainwright & Co. | → 11 美元 | 重申 | → 購買 |
| 06/06/2023 | 1310.26% | HC Wainwright & Co. | → 11 美元 | 重申 | 購買 → 購買 |
| 05/25/2023 | 1310.26% | HC Wainwright & Co. | → 11 美元 | 重申 | → 購買 |
| 05/16/2023 | 1310.26% | HC Wainwright & Co. | → 11 美元 | 重申 | 購買 → 購買 |
| 04/21/2023 | 1310.26% | HC Wainwright & Co. | → 11 美元 | 升級 | 中性 → 買入 |
| 03/01/2022 | 797.44% | 拉登堡塔爾曼 | → 7 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 05/18/2021 | 412.82% | 古根海姆 | → 4 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 12/22/2020 | — | 貴族資本市場 | 升級 | 市場表現 → 跑贏大盤 | |
| 2020 年 8 月 24 日 | — | HC Wainwright & Co. | 降級 | 買入 → 中性 | |
| 2019 年 7 月 25 日 | 1438.46% | 貴族資本市場 | → 12 美元 | 啓動覆蓋範圍開啓 | → 跑贏大盤 |
What is the target price for Onconova Therapeutics (ONTX)?
Onconova Therapeutics（ONTX）的目標價格是多少？
The latest price target for Onconova Therapeutics (NASDAQ: ONTX) was reported by HC Wainwright & Co. on October 12, 2023. The analyst firm set a price target for $11.00 expecting ONTX to rise to within 12 months (a possible 1310.26% upside). 7 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2023年10月12日公佈了Onconova Therapeutics（納斯達克股票代碼：ONTX）的最新目標股價。該分析公司將目標股價定爲11.00美元，預計ONTX將在12個月內上漲至1310.26％（可能上漲1310.26％）。去年有7家分析公司公佈了評級。
What is the most recent analyst rating for Onconova Therapeutics (ONTX)?
分析師對Onconova Therapeutics（ONTX）的最新評級是多少？
The latest analyst rating for Onconova Therapeutics (NASDAQ: ONTX) was provided by HC Wainwright & Co., and Onconova Therapeutics reiterated their buy rating.
Onconova Therapeutics（納斯達克股票代碼：ONTX）的最新分析師評級由HC Wainwright & Co. 提供，Onconova Therapeutics重申了他們的買入評級。
When is the next analyst rating going to be posted or updated for Onconova Therapeutics (ONTX)?
Onconova Therapeutics（ONTX）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Onconova Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Onconova Therapeutics was filed on October 12, 2023 so you should expect the next rating to be made available sometime around October 12, 2024.
分析師在進行了廣泛的研究後得出了股票評級，包括閱讀公開財務報表、與Onconova Therapeutics的高管和客戶交談以及聽取業績電話會議。大多數分析師每三個月進行一次評級，因此每家公司每年應獲得4個評級。Onconova Therapeutics的最後一次評級是在2023年10月12日提交的，因此你應該預計下一個評級將在2024年10月12日左右公佈。
Is the Analyst Rating Onconova Therapeutics (ONTX) correct?
分析師對 Onconova Therapeutics (ONTX) 的評級正確嗎？
While ratings are subjective and will change, the latest Onconova Therapeutics (ONTX) rating was a reiterated with a price target of $11.00 to $11.00. The current price Onconova Therapeutics (ONTX) is trading at is $0.78, which is out of the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但重申了最新的Onconova Therapeutics（ONTX）評級，目標股價爲11.00美元至11.00美元。Onconova Therapeutics（ONTX）目前的交易價格爲0.78美元，超出了分析師的預測區間。
譯文內容由第三人軟體翻譯。
